Company profile
NexgenRx Inc.
OTC: NEGXF · Healthcare · Medical - Healthcare Information Services
Canadian filerHQ Toronto, ONReports USD
#603 of 1,418 Healthcare companies by revenue47th-percentile growth
EA Score
71BFH 78DQ —GM 63SS 44
v0.1 · 45/100 weight · provisional
↑ return on equity, Piotroski F · ↓ workforce scale, balance-sheet leverage
Methodology →Revenue TTM
$13.8M
Rev growth YoY (TTM)
+13.1%
Net income (FY)
$921.9k
Employees
20
as of 2026-08-21
Market cap
$23.1M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$12.5M17.5M CAD2025
Net income$921.9k1.3M CAD2025
Operating income$1.3M1.8M CAD2025
Total assets$26.7M36.6M CAD2025
Liabilities$21.1M29.0M CAD2025
Equity$5.6M7.6M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is NexgenRx Inc.’s revenue?
NexgenRx Inc. booked $12.5M in FY2025 revenue, growing 3.9% year over year — about the middle of the pack among Healthcare companies we track, at a 7.4% net margin.
Peers · Healthcare
Leveljump Healthcare Corp.——Spero Therapeutics, Inc.68BLumos Diagnostics Holdings Ltd.45DClearday, Inc.——Medical Marijuana, Inc.58CEmmaus Life Sciences, Inc.40DKey facts
CEORonald C. Loucks
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersToronto, ON
ExchangeOTC: NEGXF
Employees20
IPO date2017-12-18
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.